Atmosphere-ph.ru

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru

ИНТЕРНЕТ-МАГАЗИН

Лечебное дело
2021 / N 4

Остеонекроз головки бедренной кости, не связанный с травмой: хирургические и консервативные методы лечения (часть 2)
Н.А. Шостак, А.А. Клименко, Н.А. Демидова, Д.Ю. Андрияшкина, А.П. Ратьев, А.В. Чирков, Г.Р. Аветисян, Е.П. Михеева

Список литературы

1. Roth A, Beckmann J, Bohndorf K, Heiß C, Jäger M, Landgraeber S, Maus U, Nöth U, Peters MK, Rader C, Reppenhagen S, Smolenski U, Kopp I, Tingart M. [Update of the German S3 guideline on atraumatic femoral head necrosis in adults]. Der Orthopade 2018;47(9):757-69.
2. Lespasio MJ, Sodhi N, Mont MA. Osteonecrosis of the hip: a primer. The Permanente Journal 2019;23:18-100.
3. Шостак Н.А., Демидова Н.А., Кондрашов А.А., Андрияшкина Д.Ю., Ратьев А.П., Аветисян Г.Р., Чирков А.В., Михеева Е.П., Морозова Е.О. Остеонекроз головки бедренной кости, не связанный с травмой: патогенетические аспекты, клиническая и инструментальная картина (часть 1). Лечебное дело 2021;2:4-16.
4. Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update. The Journal of Bone and Joint Surgery. American Volume 2015 Oct;97(19):1604-27.
5. Petek D, Hannouche D, Suva D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFORT Open Reviews 2019 Mar;4(3):85-97.
6. Roth A, Beckmann J, Smolenski U, Fischer A, Jäger M, Tingart M, Rader C, Peters KM, Reppenhagen S, Nöth U, Heiss C, Maus U. [S3 guideline. Part 2: non-traumatic avascular femoral head necrosis in adults – untreated course and conservative treatment]. Zeitschrift für Orthopädie und Unfallchirurgie 2015;153(5):488-97.
7. Chen L, Hong G, Fang B, Zhou G, Han X, Guan T, He W. Predicting the collapse of the femoral head due to osteonecrosis: from basic methods to application prospects. Journal of Orthopaedic Translation 2017 Jan;11:62-72.
8. Osmani F, Thakkar S, Vigdorchik J. The utility of conservative treatment modalities in the management of osteonecrosis. Bulletin of the Hospital for Joint Diseases 2017 May;75(3):186-92.
9. Kubo T, Ueshima K, Saito M, Ishida M, Arai Y, Fujiwara H. Clinical and basic research on steroid-induced osteonecrosis of the femoral head in Japan. Journal of Orthopaedic Science 2016 Jul;21(4):407-13.
10. Baig SA, Baig MN. Osteonecrosis of the femoral head: etiology, investigations, and management. Cureus 2018 Aug;10(8):e3171.
11. Gasbarra E, Perrone FL, Baldi J, Bilotta V, Moretti A, Tarantino U. Conservative surgery for the treatment of osteonecrosis of the femoral head: current options. Clinical Cases in Mineral and Bone Metabolism 2015 Jan-Apr;12(Suppl 1):43-50.
12. Kim SY, Kim DH, Park IH. Multiple drilling compared with core decompression for the treatment of osteonecrosis of the femoral head. The Journal of Bone and Joint Surgery 2004;86:149.
13. Marker DR, Seyler TM, Ulrich SD, Srivastava S, Mont MA. Do modern techniques improve core decompression outcomes for hip osteonecrosis? Clinical Orthopaedics and Related Research 2008 May;466(5):1093-103.
14. Song WS, Yoo JJ, Kim YM, Kim HJ. Results of multiple drilling compared with those of conventional methods of core decompression. Clinical Orthopaedics and Related Research 2007 Jan;454:139-46.
15. Tanzer M, Karabasz D, Krygier JJ, Cohen R, Bobyn JD. The Otto Aufranc Award: bone augmentation around and within porous implants by local bisphosphonate elution. Clinical Orthopaedics and Related Research 2005 Dec;441:30-9.
16. Urbaniak JR, Harvey EJ. Revascularization of the femoral head in osteonecrosis. The Journal of the American Academy of Orthopaedic Surgeons 1998 Jan-Feb;6(1):44-54.
17. Papapietro N, Martino AD, Niccoli G, Palumbo A, Salvatore G, Forriol F, Denaro V. Trabecular metal screw implanted for avascular necrosis of the femoral head may complicate subsequent arthroplasty surgery. European Journal of Orthopaedic Surgery & Traumatology 2014 Aug;24(6):931-8.
18. Mello DCR, de Oliveira JR, Cairo CAA, de Brito Ramos LS, da Cruz Vegian MR, de Vasconcellos LGO, de Oliveira FE, de Oliveira LD, de Vasconcellos LMR. Titanium alloys: in vitro biological analyzes on biofilm formation, biocompatibility, cell differentiation to induce bone formation, and immunological response. Journal of Materials Science. Materials in Medicine 2019 Sep;30(9):108.
19. Niinomi M, Liu Y, Nakai M, Liu H, Li H. Biomedical titanium alloys with Young’s moduli close to that of cortical bone. Regenerative Biomaterials 2016 Sep;3(3):173-85.
20. Lu Y, Lu X, Li M, Chen X, Liu Y, Feng X, Yu J, Zhang C, Niu D, Wang S, Wang Z, Lu J. Minimally invasive treatment for osteonecrosis of the femoral head with angioconductive bioceramic rod. International Orthopaedics 2018 Jul;42(7):1567-73.
21. Li Y, Li B, Song Y, Ma A, Li C, Zhang X, Li H, Zhang Q, Zhang K. Improved osteoblast adhesion and osseointegration on TiO2 nanotubes surface with hydroxyapatite coating. Dental Materials Journal 2019 Mar;38(2):278-86.
22. Seyler TM, Marker DR, Ulrich SD, Fatscher T, Mont MA. Nonvascularized bone grafting defers joint arthroplasty in hip osteonecrosis. Clinical Orthopaedics and Related Research 2008 May;466(5):1125-32.
23. Sun W, Li Z, Gao F, Shi Z, Zhang Q, Guo W. Recombinant human bone morphogenetic protein-2 in debridement and impacted bone graft for the treatment of femoral head osteonecrosis. PLOS One 2014 Jun;9(6):e100424.
24. Tomaru Y, Yoshioka T, Sugaya H, Aoto K, Wada H, Akaogi H, Yamazaki M, Mishima H. Hip preserving surgery with concentrated autologous bone marrow aspirate transplantation for the treatment of asymptomatic osteonecrosis of the femoral head: retrospective review of clinical and radiological outcomes at 6 years postoperatively. BMC Musculoskeletal Disorders 2017 Jul;18(1):292.
25. Cuervas-Mons M, Narbona J, Laguna R, Vaquero J. [Autologous concentrated bone marrow graft in the treatment of femoral head avascular necrosis: clinical outcome after two years of follow up in a non-controlled prospective study]. Revista Española de Cirugía Ortopédica y Traumatología 2013 Mar-Apr;57(2):106-10.
26. Hernigou P. Cellular therapy for the treatment of osteonecrosis: from bench to bedside. Instructional Course Lectures 2020;69:139-48.
27. Emadedin M, Karimi S, Karimi A, Labibzadeh N, Niknejadi M, Baharvand H, Aghdami N. Autologous bone marrow-derived CD133 cells with core decompression as a novel treatment method for femoral head osteonecrosis: a pilot study. Cytotherapy 2019 Jan;21(1):107-12.
28. Wang Z, Sun QM, Zhang FQ, Zhang QL, Wang LG, Wang WJ. Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: a meta-analysis. International Journal of Surgery (London, England) 2019 Sep;69:23-31.
29. Hauzeur JP, Lechanteur C, Baudoux E, De Maertelaer V, Pather S, Katz R, Malaise M, Ino J, Beguin Y. Did osteoblastic cell therapy improve the prognosis of pre-fracture osteonecrosis of the femoral head? A randomized, controlled trial. Clinical Orthopaedics and Related Research 2020 Jun;478(6):1307-15.
30. Yoon BH, Lee YK, Kim KC, Ha YC, Koo KH. No differences in the efficacy among various core decompression modalities and non-operative treatment: a network meta-analysis. International Orthopaedics 2018 Dec;42(12):2737-43.
31. Liu LH, Zhang QY, Sun W, Li ZR, Gao FQ. Corticosteroid-induced osteonecrosis of the femoral head: detection, diagnosis, and treatment in earlier stages. Chinese Medical Journal 2017 Nov;130(21):2601-7.
32. Zhao D, Ma Z. Application of biomaterials for the repair and treatment of osteonecrosis of the femoral head. Regenerative Biomaterials 2020 Feb;7(1):1-8.
33. Baig MN, Baig U, Curtin B. Challenges in hip replacement in hip dysplasia cases and the happy elephant sign. Cureus 2018 Jun;10(6):e2762.
34. Kakaria HL, Sharma AK, Sebastian B. Total hip replacement in avascular necrosis of femoral head. Medical Journal Armed Forces India 2005 Jan;61(1):33-5.
35. Issa K, Pivec R, Kapadia BH, Banerjee S, Mont MA. Osteonecrosis of the femoral head: the total hip replacement solution. The Bone & Joint Journal 2013 Nov;95-B(11 Suppl A):46-50.
36. Медицинская ассоциация по остеонекрозу. Доступно по: https://osteonecrosis.ru/patient/#block636 Ссылка активна на 07.02.2022.
37. Erivan R, Riouach H, Villatte G, Pereira B, Descamps S, Boisgard S. Hip preserving surgery for avascular hip necrosis: does terminating exposure to known risk factors improve survival? The Physician and Sports Medicine 2020 Sep;48(3):335-41.
38. Угнивенко В.И. Асептический некроз головки бедренной кости. Доступно по: http://www.rusmedserv.com/orthopaedics/necr.htm Ссылка активна на 07.02.2022.
39. Торгашин А.Н., Родионова С.С., Шумский А.А., Макаров М.А., Торгашина А.В., Ахтямов И.Ф., Коваленко А.Н., Загородний Н.В., Миронов С.П. Лечение асептического некроза головки бедренной кости. Клинические рекомендации. Научно-практическая ревматология 2020;58(6):637-45.
40. Yin TC, Wang CJ, Yang KD, Wang FS, Sun YC. Shockwaves enhance the osteogenetic gene expression in marrow stromal cells from hips with osteonecrosis. Chang Gung Medical Journal 2011 Jul-Aug;34(4):367-74.
41. Xie K, Mao Y, Qu X, Dai K, Jia Q, Zhu Z, Yan M. High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head. Journal of Orthopaedic Surgery and Research 2018 Feb;13(1):25.
42. Wang CJ, Wang FS, Huang CC, Yang KD, Weng LH, Huang HY. Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. The Journal of Bone and Joint Surgery 2005 Nov;87(11):2380-7.
43. Wang CJ, Huang CC, Wang JW, Wong T, Yang YJ. Long-term results of extracorporeal shockwave therapy and core decompression in osteonecrosis of the femoral head with eight- to nine-year follow-up. Biomedical Journal 2012 Nov-Dec;35(6):481-5.
44. Wang CJ, Cheng JH, Huang CC, Yip HK, Russo S. Extracorporeal shockwave therapy for avascular necrosis of femoral head. International Journal of Surgery (London, England) 2015 Dec;24(Pt B):184-7.
45. Trock DH. Electromagnetic fields and magnets. Investigational treatment for musculoskeletal disorders. Rheumatic Diseases Clinics of North America 2000 Feb;26(1):51-62, viii.
46. Al-Jabri T, Tan JYQ, Tong GY, Shenoy R, Kayani B, Parratt T, Khan T. The role of electrical stimulation in the management of avascular necrosis of the femoral head in adults: a systematic review. BMC Musculoskeletal Disorders 2017 Jul;18(1):319.
47. Massari L, Fini M, Cadossi R, Setti S, Traina GC. Biophysical stimulation with pulsed electromagnetic fields in osteonecrosis of the femoral head. The Journal of Bone and Joint Surgery. American Volume 2006 Nov;88(Suppl 3):56-60.
48. Aaron RK. Treatment of osteonecrosis of the femoral head with electrical stimulation. Instructional Course Lectures 1994;43:495-8.
49. Windisch C, Kolb W, Röhner E, Wagner M, Roth A, Matziolis G, Wagner A. Invasive electromagnetic field treatment in osteonecrosis of the femoral head: a prospective cohort study. The Open Orthopaedics Journal 2014 Jun;8:125-9.
50. Koren L, Ginesin E, Melamed Y, Norman D, Levin D, Peled E. Hyperbaric oxygen for stage I and II femoral head osteonecrosis. Orthopedics 2015 Mar;38(3):e200-5.
51. Thom SR. Oxidative stress is fundamental to hyperbaric oxygen therapy. Journal of Applied Physiology (Bethesda, Md.: 1985) 2009 Mar;106(3):988-95.
52. Bosco G, Vezzani G, Sposta SM, Rizzato A, Enten G, Abou-Samra A, Malacrida S, Quartesan S, Vezzoli A, Camporesi E. Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress. Journal of Enzyme Inhibition and Medicinal Chemistry 2018 Dec;33(1):1501-5.
53. Mathieu D, Marroni A, Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving and Hyperbaric Medicine 2017 Mar;47(1):24-32.
54. Vezzani G, Camporesi EM, Mangar D, Bernasek T, Yang Z, Quartesan S, Rizzato A, Bosco G. Beneficial effect of hyperbaric oxygenation in avascular necrosis of the femoral head. Gazzetta Medica Italiana Archivio per le Scienze Mediche 2018 Mar;177(3):72-8.
55. Sung PH, Yang YH, Chiang HJ, Chiang JY, Chen CJ, Yip HK, Lee MS. Cardiovascular and cerebrovascular events are associated with nontraumatic osteonecrosis of the femoral head. Clinical Orthopaedics and Related Research 2018 Apr;476(4):865-74.
56. Ассоциация ревматологов России; Российское общество по изучению боли; Российская гастроэнтерологическая ассоциация; Российское научное медицинское общество терапевтов; Ассоциация травматологов-ортопедов России; Российская ассоциация паллиативной медицины. Рациональное использование нестероидных противовоспалительных препаратов (НПВП) в клинической практике. Клинические рекомендации. Научно-практическая ревматология 2018;56(прил. 1):1-29.
57. Миронов С.П., Родионова С.С., Шумский A.A. Медицинская технология ФС №2011/250 «Фармакологическая терапия ранних стадий асептического некроза головки бедренной кости», 22.08.2011. Москва, ФГУ ЦИТО им. H.H. Приорова.
58. Министерство здравоохранения Российской Федерации; Российская ассоциация эндокринологов; Эндокринологический научный центр. Клинические рекомендации. Дефицит витамина D у взрослых: диагностика, лечение и профилактика. М., 2015 г. 75 с. Доступно по: https://minzdrav.gov-murman.ru/documents/poryadki-okazaniya-meditsinskoy-pomoshchi/D%2019042014.pdf Ссылка активна на 10.02.2022.
59. Young ML, Little DG, Kim HK. Evidence for using bisphosphonate to treat Legg-Calvé-Perthes disease. Clinical Orthopaedics and Related Research 2012 Sep;470(9):2462-75.
60. Agarwala S, Vijayvargiya M. Bisphosphonate combination therapy for non-femoral avascular necrosis. Journal of Orthopaedic Surgery and Research 2019 Apr;14(1):112.
61. Agarwala S, Shah S, Joshi VR. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years. The Journal of Bone and Joint Surgery. British Volume 2009 Aug;91(8):1013-8.
62. Luo RB, Lin T, Zhong HM, Yan SG, Wang JA. Evidence for using alendronate to treat adult avascular necrosis of the femoral head: a systematic review. Medical Science Monitor 2014 Nov;20:2439-47.
63. Li D, Yang Z, Wei Z, Kang P. Efficacy of bisphosphonates in the treatment of femoral head osteonecrosis: a PRISMA-compliant meta-analysis of animal studies and clinical trials. Scientific Reports 2018 Jan;8(1):1450.
64. Yuan HF, Guo CA, Yan ZQ. The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials. Osteoporosis International 2016 Jan;27(1):295-9.
65. Rolvien T, Schmidt T, Butscheidt S, Amling M, Barvencik F. Denosumab is effective in the treatment of bone marrow oedema syndrome. Injury 2017 Apr;48(4):874-9.
66. Claßen T, Becker A, Landgraeber S, Haversath M, Li X, Zilkens C, Krauspe R, Jäger M. Long-term clinical results after iloprost treatment for bone marrow edema and avascular necrosis. Orthopedic Reviews 2016 Mar;8(1):6150.
67. Pountos I, Giannoudis PV. The role of iloprost on bone edema and osteonecrosis: safety and clinical results. Expert Opinion on Drug Safety 2018 Mar;17(3):225-33.
68. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clinical Orthopaedics and Related Research 2005 Jun;435:164-70.
69. Chotanaphuti T, Thongprasert S, Laoruengthana AJ. Low molecular weight heparin prevents the progression of precollapse osteonecrosis of the hip. Journal of the Medical Association of Thailand 2013 Oct;96(10):1326-30.
70. Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y. Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis & Rheumatology 2004 Oct;50(10):3387-91.
71. Albers A, Carli A, Routy B, Harvey EJ, Séguin C. Treatment with acetylsalicylic acid prevents short to mid-term radiographic progression of nontraumatic osteonecrosis of the femoral head: a pilot study. Canadian Journal of Surgery 2015 Jun;58(3):198-205.
72. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clinical Orthopaedics and Related Research 2001 May;386:173-8.
73. Lee YJ, Cui Q, Koo KH. Is there a role of pharmacological treatments in the prevention or treatment of osteonecrosis of the femoral head? A systematic review. Journal of Bone Metabolism 2019 Feb;26(1):13-8.
74. Han N, Li Z, Cai Z, Yan Z, Hua Y, Xu C. P-glycoprotein overexpression in bone marrow-derived multipotent stromal cells decreases the risk of steroid-induced osteonecrosis in the femoral head. Journal of Cellular and Molecular Medicine 2016;20(11):2173-82.
75. Hang D, Wang Q, Guo C, Chen Z, Yan Z. Treatment of osteonecrosis of the femoral head with VEGF165 transgenic bone marrow mesenchymal stem cells in mongrel dogs. Cells, Tissues, Organs 2012;195(6):495-506.
76. Zhang F, Peng WX, Wang L, Zhang J, Dong WT, Wu JH, Zhang H, Wang JB, Zhao Y. Role of FGF-2 transfected bone marrow mesenchymal stem cells in engineered bone tissue for repair of avascular necrosis of femoral head in rabbits. Cellular Physiology and Biochemistry 2018;48(2):773-84.
77. Park BH, Jang KY, Kim KH, Song KH, Lee SY, Yoon SJ, Kwon KS, Yoo WH, Koh YJ, Yoon KH, Son HH, Koh GY, Kim JR. COMP-angiopoietin-1 ameliorates surgery-induced ischemic necrosis of the femoral head in rats. Bone 2009 May;44(5):886-92.
78. Kong L, Zuo R, Wang M, Wang W, Xu J, Chai Y, Guan J, Kang Q.. Silencing microRNA-137-3p, which targets RUNX2 and CXCL12 prevents steroid-induced osteonecrosis of the femoral head by facilitating osteogenesis and angiogenesis. International Journal of Biological Sciences 2020 Jan;16(4):655-70.
79. Park SH, Kang MA, Moon YJ, Jang KY, Kim JR. Metformin coordinates osteoblast/osteoclast differentiation associated with ischemic osteonecrosis. Aging (Albany, NY) 2020 Feb;12(6):4727-41.
80. Wang P, Ma T, Guo D, Hu K, Shu Y, Xu HHK, Schneider A. Metformin induces osteoblastic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells. Journal of Tissue Engineering and Regenerative Medicine 2018 Feb;12(2):437-46.
81. Zhou L, Yoon SJ, Jang KY, Moon YJ, Wagle S, Lee KB, Park BH, Kim JR. COMP-angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats. PLoS One 2014 Oct;9:e110593.

References

1. Roth A, Beckmann J, Bohndorf K, Heiß C, Jäger M, Landgraeber S, Maus U, Nöth U, Peters MK, Rader C, Reppenhagen S, Smolenski U, Kopp I, Tingart M. [Update of the German S3 guideline on atraumatic femoral head necrosis in adults]. Der Orthopade 2018;47(9):757-69.
2. Lespasio MJ, Sodhi N, Mont MA. Osteonecrosis of the hip: a primer. The Permanente Journal 2019;23:18-100.
3. Shostak NA, Demidova NA, Kondrashov AA, Andriyashkina DYu, Ratyev AP, Avetisyan GR, Chirkov AV, Mikheyeva EP, Morozova EO. Osteonecrosis of femoral head not associated with trauma: pathogenetic aspects, clinical, and instrumental picture: part 1. Lechebnoye Delo 2021;2:4-16 (In Russian).
4. Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update. The Journal of Bone and Joint Surgery. American Volume 2015 Oct;97(19):1604-27.
5. Petek D, Hannouche D, Suva D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFORT Open Reviews 2019 Mar;4(3):85-97.
6. Roth A, Beckmann J, Smolenski U, Fischer A, Jäger M, Tingart M, Rader C, Peters KM, Reppenhagen S, Nöth U, Heiss C, Maus U. [S3 guideline. Part 2: non-traumatic avascular femoral head necrosis in adults – untreated course and conservative treatment]. Zeitschrift für Orthopädie und Unfallchirurgie 2015;153(5):488-97.
7. Chen L, Hong G, Fang B, Zhou G, Han X, Guan T, He W. Predicting the collapse of the femoral head due to osteonecrosis: from basic methods to application prospects. Journal of Orthopaedic Translation 2017 Jan;11:62-72.
8. Osmani F, Thakkar S, Vigdorchik J. The utility of conservative treatment modalities in the management of osteonecrosis. Bulletin of the Hospital for Joint Diseases 2017 May;75(3):186-92.
9. Kubo T, Ueshima K, Saito M, Ishida M, Arai Y, Fujiwara H. Clinical and basic research on steroid-induced osteonecrosis of the femoral head in Japan. Journal of Orthopaedic Science 2016 Jul;21(4):407-13.
10. Baig SA, Baig MN. Osteonecrosis of the femoral head: etiology, investigations, and management. Cureus 2018 Aug;10(8):e3171.
11. Gasbarra E, Perrone FL, Baldi J, Bilotta V, Moretti A, Tarantino U. Conservative surgery for the treatment of osteonecrosis of the femoral head: current options. Clinical Cases in Mineral and Bone Metabolism 2015 Jan-Apr;12(Suppl 1):43-50.
12. Kim SY, Kim DH, Park IH. Multiple drilling compared with core decompression for the treatment of osteonecrosis of the femoral head. The Journal of Bone and Joint Surgery 2004;86:149.
13. Marker DR, Seyler TM, Ulrich SD, Srivastava S, Mont MA. Do modern techniques improve core decompression outcomes for hip osteonecrosis? Clinical Orthopaedics and Related Research 2008 May;466(5):1093-103.
14. Song WS, Yoo JJ, Kim YM, Kim HJ. Results of multiple drilling compared with those of conventional methods of core decompression. Clinical Orthopaedics and Related Research 2007 Jan;454:139-46.
15. Tanzer M, Karabasz D, Krygier JJ, Cohen R, Bobyn JD. The Otto Aufranc Award: bone augmentation around and within porous implants by local bisphosphonate elution. Clinical Orthopaedics and Related Research 2005 Dec;441:30-9.
16. Urbaniak JR, Harvey EJ. Revascularization of the femoral head in osteonecrosis. The Journal of the American Academy of Orthopaedic Surgeons 1998 Jan-Feb;6(1):44-54.
17. Papapietro N, Martino AD, Niccoli G, Palumbo A, Salvatore G, Forriol F, Denaro V. Trabecular metal screw implanted for avascular necrosis of the femoral head may complicate subsequent arthroplasty surgery. European Journal of Orthopaedic Surgery & Traumatology 2014 Aug;24(6):931-8.
18. Mello DCR, de Oliveira JR, Cairo CAA, de Brito Ramos LS, da Cruz Vegian MR, de Vasconcellos LGO, de Oliveira FE, de Oliveira LD, de Vasconcellos LMR. Titanium alloys: in vitro biological analyzes on biofilm formation, biocompatibility, cell differentiation to induce bone formation, and immunological response. Journal of Materials Science. Materials in Medicine 2019 Sep;30(9):108.
19. Niinomi M, Liu Y, Nakai M, Liu H, Li H. Biomedical titanium alloys with Young’s moduli close to that of cortical bone. Regenerative Biomaterials 2016 Sep;3(3):173-85.
20. Lu Y, Lu X, Li M, Chen X, Liu Y, Feng X, Yu J, Zhang C, Niu D, Wang S, Wang Z, Lu J. Minimally invasive treatment for osteonecrosis of the femoral head with angioconductive bioceramic rod. International Orthopaedics 2018 Jul;42(7):1567-73.
21. Li Y, Li B, Song Y, Ma A, Li C, Zhang X, Li H, Zhang Q, Zhang K. Improved osteoblast adhesion and osseointegration on TiO2 nanotubes surface with hydroxyapatite coating. Dental Materials Journal 2019 Mar;38(2):278-86.
22. Seyler TM, Marker DR, Ulrich SD, Fatscher T, Mont MA. Nonvascularized bone grafting defers joint arthroplasty in hip osteonecrosis. Clinical Orthopaedics and Related Research 2008 May;466(5):1125-32.
23. Sun W, Li Z, Gao F, Shi Z, Zhang Q, Guo W. Recombinant human bone morphogenetic protein-2 in debridement and impacted bone graft for the treatment of femoral head osteonecrosis. PLOS One 2014 Jun;9(6):e100424.
24. Tomaru Y, Yoshioka T, Sugaya H, Aoto K, Wada H, Akaogi H, Yamazaki M, Mishima H. Hip preserving surgery with concentrated autologous bone marrow aspirate transplantation for the treatment of asymptomatic osteonecrosis of the femoral head: retrospective review of clinical and radiological outcomes at 6 years postoperatively. BMC Musculoskeletal Disorders 2017 Jul;18(1):292.
25. Cuervas-Mons M, Narbona J, Laguna R, Vaquero J. [Autologous concentrated bone marrow graft in the treatment of femoral head avascular necrosis: clinical outcome after two years of follow up in a non-controlled prospective study]. Revista Española de Cirugía Ortopédica y Traumatología 2013 Mar-Apr;57(2):106-10.
26. Hernigou P. Cellular therapy for the treatment of osteonecrosis: from bench to bedside. Instructional Course Lectures 2020;69:139-48.
27. Emadedin M, Karimi S, Karimi A, Labibzadeh N, Niknejadi M, Baharvand H, Aghdami N. Autologous bone marrow-derived CD133 cells with core decompression as a novel treatment method for femoral head osteonecrosis: a pilot study. Cytotherapy 2019 Jan;21(1):107-12.
28. Wang Z, Sun QM, Zhang FQ, Zhang QL, Wang LG, Wang WJ. Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: a meta-analysis. International Journal of Surgery (London, England) 2019 Sep;69:23-31.
29. Hauzeur JP, Lechanteur C, Baudoux E, De Maertelaer V, Pather S, Katz R, Malaise M, Ino J, Beguin Y. Did osteoblastic cell therapy improve the prognosis of pre-fracture osteonecrosis of the femoral head? A randomized, controlled trial. Clinical Orthopaedics and Related Research 2020 Jun;478(6):1307-15.
30. Yoon BH, Lee YK, Kim KC, Ha YC, Koo KH. No differences in the efficacy among various core decompression modalities and non-operative treatment: a network meta-analysis. International Orthopaedics 2018 Dec;42(12):2737-43.
31. Liu LH, Zhang QY, Sun W, Li ZR, Gao FQ. Corticosteroid-induced osteonecrosis of the femoral head: detection, diagnosis, and treatment in earlier stages. Chinese Medical Journal 2017 Nov;130(21):2601-7.
32. Zhao D, Ma Z. Application of biomaterials for the repair and treatment of osteonecrosis of the femoral head. Regenerative Biomaterials 2020 Feb;7(1):1-8.
33. Baig MN, Baig U, Curtin B. Challenges in hip replacement in hip dysplasia cases and the happy elephant sign. Cureus 2018 Jun;10(6):e2762.
34. Kakaria HL, Sharma AK, Sebastian B. Total hip replacement in avascular necrosis of femoral head. Medical Journal Armed Forces India 2005 Jan;61(1):33-5.
35. Issa K, Pivec R, Kapadia BH, Banerjee S, Mont MA. Osteonecrosis of the femoral head: the total hip replacement solution. The Bone & Joint Journal 2013 Nov;95-B(11 Suppl A):46-50.
36. Medical Association for Osteonecrosis. Available from: https://osteonecrosis.ru/patient/#block636 Accessed 2022 Feb 07 (In Russian).
37. Erivan R, Riouach H, Villatte G, Pereira B, Descamps S, Boisgard S. Hip preserving surgery for avascular hip necrosis: does terminating exposure to known risk factors improve survival? The Physician and Sports Medicine 2020 Sep;48(3):335-41.
38. Ugnivenko VI. Aseptic necrosis of the femoral head. Available from: http://www.rusmedserv.com/orthopaedics/necr.htm Accessed 2022 Feb 07. (In Russian).
39. Torgashin AN, Rodionova SS, Shumskiy AA, Makarov MA, Torgashina AV, Akhtyamov IF, Kovalenko AN, Zagorodniy NV, Mironov SP. Treatment of aseptic necrosis of femoral head. Clinical guidelines. Rheumatology Science and Practice 2020;58(6):637-45 (In Russian).
40. Yin TC, Wang CJ, Yang KD, Wang FS, Sun YC. Shockwaves enhance the osteogenetic gene expression in marrow stromal cells from hips with osteonecrosis. Chang Gung Medical Journal 2011 Jul-Aug;34(4):367-74.
41. Xie K, Mao Y, Qu X, Dai K, Jia Q, Zhu Z, Yan M. High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head. Journal of Orthopaedic Surgery and Research 2018;13(1):25.
42. Wang CJ, Wang FS, Huang CC, Yang KD, Weng LH, Huang HY. Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. The Journal of Bone and Joint Surgery 2005 Nov;87(11):2380-7.
43. Wang CJ, Huang CC, Wang JW, Wong T, Yang YJ. Long-term results of extracorporeal shockwave therapy and core decompression in osteonecrosis of the femoral head with eight- to nine-year follow-up. Biomedical Journal 2012;35(6):481-5.
44. Wang CJ, Cheng JH, Huang CC, Yip HK, Russo S. Extracorporeal shockwave therapy for avascular necrosis of femoral head. International Journal of Surgery (London, England) 2015 Dec;24(Pt B):184-7.
45. Trock DH. Electromagnetic fields and magnets. Investigational treatment for musculoskeletal disorders. Rheumatic Diseases Clinics of North America 2000 Feb;26(1):51-62, viii.
46. Al-Jabri T, Tan JYQ, Tong GY, Shenoy R, Kayani B, Parratt T, Khan T. The role of electrical stimulation in the management of avascular necrosis of the femoral head in adults: a systematic review. BMC Musculoskeletal Disorders 2017 Jul;18(1):319.
47. Massari L, Fini M, Cadossi R, Setti S, Traina GC. Biophysical stimulation with pulsed electromagnetic fields in osteonecrosis of the femoral head. The Journal of Bone and Joint Surgery. American Volume 2006 Nov;88(Suppl 3):56-60.
48. Aaron RK. Treatment of osteonecrosis of the femoral head with electrical stimulation. Instructional Course Lectures 1994;43:495-8.
49. Windisch C, Kolb W, Rohner E, Wagner M, Roth A, Matziolis G, Wagner A. Invasive electromagnetic field treatment in osteonecrosis of the femoral head: a prospective cohort study. The Open Orthopaedics Journal 2014 Jun;8:125-9.
50. Koren L, Ginesin E, Melamed Y, Norman D, Levin D, Peled E. Hyperbaric oxygen for stage I and II femoral head osteonecrosis. Orthopedics 2015 Mar;38(3):e200-5.
51. Thom SR. Oxidative stress is fundamental to hyperbaric oxygen therapy. Journal of Applied Physiology (Bethesda, Md.: 1985) 2009 Mar;106(3):988-95.
52. Bosco G, Vezzani G, Sposta SM, Rizzato A, Enten G, Abou-Samra A, Malacrida S, Quartesan S, Vezzoli A, Camporesi E. Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress. Journal of Enzyme Inhibition and Medicinal Chemistry 2018 Dec;33(1):1501-5.
53. Mathieu D, Marroni A, Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving and Hyperbaric Medicine 2017 Mar;47(1):24-32.
54. Vezzani G, Camporesi EM, Mangar D, Bernasek T, Yang Z, Quartesan S, Rizzato A, Bosco G. Beneficial effect of hyperbaric oxygenation in avascular necrosis of the femoral head. Gazzetta Medica Italiana Archivio per le Scienze Mediche 2018 Mar;177(3):72-8.
55. Sung PH, Yang YH, Chiang HJ, Chiang JY, Chen CJ, Yip HK, Lee MS. Cardiovascular and cerebrovascular events are associated with nontraumatic osteonecrosis of the femoral head. Clinical Orthopaedics and Related Research 2018 Apr;476(4):865-74.
56. Association of Rheumatologists of Russia; Russian Society for the Study of Pain; Russian Gastroenterological Association; Russian Scientific Medical Society of Therapists; Association of Traumatologists and Orthopedists of Russia; Russian Association of Palliative Medicine. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Rheumatology Science and Practice 2018;56(Suppl 1):1-29 (In Russian).
57. Mironov SP, Rodionova SS, Shumsky AA. Medical technology FS No.2011/250 "Pharmacological therapy of early stages of aseptic necrosis of the femoral head", 08/22/2011. Moscow, NN Priorov National Medical Research Center of Traumatology and Orthopedics. (In Russian).
58. Ministry of Health of the Russian Federation; Russian Association of Endocrinologists; Endocrinological Research Center. Clinical guidelines. Vitamin D deficiency in adults: diagnosis, treatment and prevention. Moscow, 2015. 75 p. Available from: https://minzdrav.gov-murman.ru/documents/poryadki-okazaniya-meditsinskoy-pomoshchi/D%2019042014.pdf Accessed 2022 Feb 10. (In Russian).
59. Young ML, Little DG, Kim HK. Evidence for using bisphosphonate to treat Legg-Calvé-Perthes disease. Clinical Orthopaedics and Related Research 2012 Sep;470(9):2462-75.
60. Agarwala S, Vijayvargiya M. Bisphosphonate combination therapy for non-femoral avascular necrosis. Journal of Orthopaedic Surgery and Research 2019 Apr;14(1):112.
61. Agarwala S, Shah S, Joshi VR. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years. The Journal of Bone and Joint Surgery. British Volume 2009 Aug;91(8):1013-8.
62. Luo RB, Lin T, Zhong HM, Yan SG, Wang JA. Evidence for using alendronate to treat adult avascular necrosis of the femoral head: a systematic review. Medical Science Monitor 2014 Nov;20:2439-47.
63. Li D, Yang Z, Wei Z, Kang P. Efficacy of bisphosphonates in the treatment of femoral head osteonecrosis: a PRISMA-compliant meta-analysis of animal studies and clinical trials. Scientific Reports 2018 Jan;8(1):1450.
64. Yuan HF, Guo CA, Yan ZQ. The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials. Osteoporosis International 2016 Jan;27(1):295-9.
65. Rolvien T, Schmidt T, Butscheidt S, Amling M, Barvencik F. Denosumab is effective in the treatment of bone marrow oedema syndrome. Injury 2017 Apr;48(4):874-9.
66. Claßen T, Becker A, Landgraeber S, Haversath M, Li X, Zilkens C, Krauspe R, Jäger M. Long-term clinical results after iloprost treatment for bone marrow edema and avascular necrosis. Orthopedic Reviews 2016 Mar;8(1):6150.
67. Pountos I, Giannoudis PV. The role of iloprost on bone edema and osteonecrosis: safety and clinical results. Expert Opinion on Drug Safety 2018 Mar;17(3):225-33.
68. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clinical Orthopaedics and Related Research 2005 Jun;435:164-70.
69. Chotanaphuti T, Thongprasert S, Laoruengthana AJ. Low molecular weight heparin prevents the progression of precollapse osteonecrosis of the hip. Journal of the Medical Association of Thailand 2013 Oct;96(10):1326-30.
70. Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y. Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis & Rheumatology 2004 Oct;50(10):3387-91.
71. Albers A, Carli A, Routy B, Harvey EJ, Séguin C. Treatment with acetylsalicylic acid prevents short to mid-term radiographic progression of nontraumatic osteonecrosis of the femoral head: a pilot study. Canadian Journal of Surgery 2015 Jun;58(3):198-205.
72. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clinical Orthopaedics and Related Research 2001 May;386:173-8.
73. Lee YJ, Cui Q, Koo KH. Is there a role of pharmacological treatments in the prevention or treatment of osteonecrosis of the femoral head? A systematic review. Journal of Bone Metabolism 2019 Feb;26(1):13-8.
74. Han N, Li Z, Cai Z, Yan Z, Hua Y, Xu C. P-glycoprotein overexpression in bone marrow-derived multipotent stromal cells decreases the risk of steroid-induced osteonecrosis in the femoral head. Journal of Cellular and Molecular Medicine 2016;20(11):2173-82.
75. Hang D, Wang Q, Guo C, Chen Z, Yan Z. Treatment of osteonecrosis of the femoral head with VEGF165 transgenic bone marrow mesenchymal stem cells in mongrel dogs. Cells, Tissues, Organs 2012;195(6):495-506.
76. Zhang F, Peng WX, Wang L, Zhang J, Dong WT, Wu JH, Zhang H, Wang JB, Zhao Y. Role of FGF-2 transfected bone marrow mesenchymal stem cells in engineered bone tissue for repair of avascular necrosis of femoral head in rabbits. Cellular Physiology and Biochemistry 2018;48(2):773-84.
77. Park BH, Jang KY, Kim KH, Song KH, Lee SY, Yoon SJ, Kwon KS, Yoo WH, Koh YJ, Yoon KH, Son HH, Koh GY, Kim JR. COMP-angiopoietin-1 ameliorates surgery-induced ischemic necrosis of the femoral head in rats. Bone 2009 May;44(5):886-92.
78. Kong L, Zuo R, Wang M, Wang W, Xu J, Chai Y, Guan J, Kang Q.. Silencing microRNA-137-3p, which targets RUNX2 and CXCL12 prevents steroid-induced osteonecrosis of the femoral head by facilitating osteogenesis and angiogenesis. International Journal of Biological Sciences 2020 Jan;16(4):655-70.
79. Park SH, Kang MA, Moon YJ, Jang KY, Kim JR. Metformin coordinates osteoblast/osteoclast differentiation associated with ischemic osteonecrosis. Aging (Albany, NY) 2020 Feb;12(6):4727-41.
80. Wang P, Ma T, Guo D, Hu K, Shu Y, Xu HHK, Schneider A. Metformin induces osteoblastic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells. Journal of Tissue Engineering and Regenerative Medicine 2018 Feb;12(2):437-46.
81. Zhou L, Yoon SJ, Jang KY, Moon YJ, Wagle S, Lee KB, Park BH, Kim JR. COMP-angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats. PLoS One 2014 Oct;9:e110593.

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]